- Home
- CAC vs PCRX Comparison
CAC vs PCRX Comparison
Compare CAC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- PCRX
- Stock Information
- Founded
- CAC 1875
- PCRX 2006
- Country
- CAC United States
- PCRX United States
- Employees
- CAC N/A
- PCRX N/A
- Industry
- CAC Major Banks
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- PCRX Health Care
- Exchange
- CAC Nasdaq
- PCRX Nasdaq
- Market Cap
- CAC 616.5M
- PCRX 604.7M
- IPO Year
- CAC 1997
- PCRX 2011
- Fundamental
- Price
- CAC $44.10
- PCRX $21.88
- Analyst Decision
- CAC Hold
- PCRX Buy
- Analyst Count
- CAC 3
- PCRX 10
- Target Price
- CAC $46.67
- PCRX $27.60
- AVG Volume (30 Days)
- CAC 79.5K
- PCRX 762.4K
- Earning Date
- CAC 01-28-2025
- PCRX 02-27-2025
- Dividend Yield
- CAC 3.82%
- PCRX N/A
- EPS Growth
- CAC N/A
- PCRX N/A
- EPS
- CAC 3.20
- PCRX N/A
- Revenue
- CAC $168,756,000.00
- PCRX $694,957,000.00
- Revenue This Year
- CAC N/A
- PCRX $4.83
- Revenue Next Year
- CAC $30.91
- PCRX $2.16
- P/E Ratio
- CAC $13.73
- PCRX N/A
- Revenue Growth
- CAC N/A
- PCRX 4.40
- 52 Week Low
- CAC $28.62
- PCRX $11.16
- 52 Week High
- CAC $50.07
- PCRX $34.01
- Technical
- Relative Strength Index (RSI)
- CAC 54.37
- PCRX 68.77
- Support Level
- CAC $40.37
- PCRX $18.18
- Resistance Level
- CAC $43.71
- PCRX $22.36
- Average True Range (ATR)
- CAC 1.08
- PCRX 1.04
- MACD
- CAC 0.19
- PCRX 0.21
- Stochastic Oscillator
- CAC 89.23
- PCRX 88.54
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.